$1.76 -0.03 (-1.68%) IntelliPharmaCeutics International Inc - NASDAQ

Aug. 31, 2016 | 03:53 PM
Last Trade: 1.76
Trade Time: Aug 31 03:53 PM Eastern Daylight Time
Change: -0.03 (-1.68%)
Prev Close: 1.79
Open: 1.79
Bid: 1.73
Ask: 1.75
  1. No results found.
  1. Mid-Afternoon Market Update: Dow Surges Over 250 Points; Ambarella Shares Tumble

    Benzinga | Jan. 14, 2016 | 14:51PM EST
  2. Mid-Day Market Update: US Stocks Turn Higher; GoPro Shares Slide On Disappointing Guidance

    Benzinga | Jan. 14, 2016 | 12:24PM EST
  3. Mid-Morning Market Update: Markets Down; JPMorgan Beats Q4 Expectations

    Benzinga | Jan. 14, 2016 | 10:06AM EST
  4. Morning Market Losers

    Benzinga | Jun. 19, 2015 | 09:53AM EST
  5. US Stock Futures Edge Lower Ahead Of Economic Data

    Benzinga | May. 26, 2015 | 07:08AM EST
  6. Intellipharmaceutics Says Final FDA Approval has Not Yet been Issued for 5 MG Strength of Generic Dexmethylphenidate Generic of Focalin XR

    Benzinga | May. 26, 2015 | 04:49AM EST
  7. Intellipharmaceutics to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, ON

    Benzinga | May. 26, 2015 | 04:47AM EST
  8. Morning Market Gainers

    Benzinga | May. 21, 2015 | 09:49AM EST
  9. Intellipharmaceutics Is 'Not Just A Generic Drug Story,' Brean Capital Says

    Benzinga | Feb. 23, 2015 | 16:56PM EST
  10. Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals

    GuruFocus | Feb. 4, 2015 | 14:39PM EST
  11. Morning Market Gainers

    Benzinga | Feb. 2, 2015 | 09:44AM EST
  12. Top Performing Industries For October 23, 2014

    Benzinga | Oct. 23, 2014 | 10:31AM EST
  13. Intellipharmaceutics Reports Positive Results From A Series of Phase I Clinical Trials Of Regabatin XR

    Benzinga | Oct. 22, 2014 | 17:15PM EST
  14. Morning Market Losers

    Benzinga | Jul. 8, 2014 | 09:45AM EST
  15. Morning Market Movers

    Benzinga | Feb. 3, 2014 | 09:58AM EST
Trading Center